Amyloid pterygium of unspecified eye
ICD-10 H11.019 is a billable code used to indicate a diagnosis of amyloid pterygium of unspecified eye.
Amyloid pterygium of the unspecified eye is a rare ocular condition characterized by the deposition of amyloid protein in the conjunctiva, leading to a yellowish-white, gelatinous appearance. This condition can affect the conjunctiva, sclera, and cornea, potentially causing discomfort, visual disturbances, or cosmetic concerns. The amyloid deposits may arise from systemic amyloidosis or localized processes, and their presence can indicate underlying systemic disease. Clinically, patients may present with a mass or thickening of the conjunctiva, which can be asymptomatic or symptomatic depending on the extent of involvement. Diagnosis is typically confirmed through histopathological examination, where Congo red staining reveals apple-green birefringence under polarized light. Disease progression can vary; while some patients may experience stable lesions, others may have progressive growth requiring intervention. Differential diagnoses include conjunctival cysts, papillomas, and other conjunctival tumors, necessitating thorough evaluation. Regular monitoring and follow-up are essential to assess for any changes in the lesions and to manage any associated symptoms effectively.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.019 specifically covers amyloid pterygium of the unspecified eye, which is characterized by amyloid deposits in the conjunctiva. It does not cover other types of pterygium or conjunctival lesions that are not related to amyloid.
H11.019 should be used when the amyloid pterygium is confirmed but the specific eye affected is not documented. If the right or left eye is specified, the corresponding codes H11.018 or H11.020 should be used.
Documentation for H11.019 should include a thorough clinical examination report, any imaging studies performed, and histopathological findings confirming the diagnosis of amyloid pterygium.
